Symmetrix Home Healthcare, Inc | |
2015 S Arlington Heights Rd Suite 101, Arlington Heights, Illinois 60005 | |
(847) 430-6771 | |
Name | Symmetrix Home Healthcare, Inc |
---|---|
Location | 2015 S Arlington Heights Rd Suite 101, Arlington Heights, Illinois |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 147994 |
Ownership Type | Proprietary |
Service Area Zip Codes | 60002, 60004, 60005, 60016, 60035, 60040, 60045, 60046, 60048, 60053, 60056, 60060, 60062, 60064, 60068, 60073, 60076, 60077, 60085, 60087, 60091, 60153, 60201, 60202, 60203, 60609, 60610, 60614, 60615, 60616, 60617, 60618, 60619, 60620, 60621, 60622, 60624, 60628, 60636, 60637, 60641, 60643, 60644, 60645, 60646, 60647, 60649, 60651, 60653, 60654, 60712, 60714 |
NPI Number | 1851411581 |
Organization Name | SYMMETRIX HOME HEALTHCARE, INC. |
Doing Business As | SYNERGY HOME HEALTHCARE, INC. |
Address | 411 Business Center Drive, Suite 106, Mt Prospect, IL 60056 |
Phone Number | 847-430-6771 |
News Archive
A team of researchers from the Universitat Autònoma de Barcelona (UAB) has discovered that transposons, small DNA sequences that travel through the genomes, can silence the genes adjacent to them by inducing a molecule called antisense RNA.
It's a scenario played out all too frequently: Adult children, worried about the safety of their aging parents, foist devices on them to monitor their safety. And their parents, resentful of having their privacy invaded and losing their independence, resist fiercely.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, is pleased to be named among the Top 50 Best Small and Medium Employers in Canada. Bioniche was ranked number 14 by its employees. Two years ago, the Company attained a 13th place ranking.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-FXIRx, an antisense drug designed to treat clotting disorders. ISIS-FXIRx inhibits the production of Factor XI, a clotting factor that is an important component of the coagulation pathway. Because of its role in the intrinsic coagulation pathway, inhibition of Factor XI could offer an effective approach for preventing the formation of blood clots with a lower risk of bleeding.
› Verified 7 days ago
Quality Rating: |
News Archive
A team of researchers from the Universitat Autònoma de Barcelona (UAB) has discovered that transposons, small DNA sequences that travel through the genomes, can silence the genes adjacent to them by inducing a molecule called antisense RNA.
It's a scenario played out all too frequently: Adult children, worried about the safety of their aging parents, foist devices on them to monitor their safety. And their parents, resentful of having their privacy invaded and losing their independence, resist fiercely.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, is pleased to be named among the Top 50 Best Small and Medium Employers in Canada. Bioniche was ranked number 14 by its employees. Two years ago, the Company attained a 13th place ranking.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-FXIRx, an antisense drug designed to treat clotting disorders. ISIS-FXIRx inhibits the production of Factor XI, a clotting factor that is an important component of the coagulation pathway. Because of its role in the intrinsic coagulation pathway, inhibition of Factor XI could offer an effective approach for preventing the formation of blood clots with a lower risk of bleeding.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 94.8 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 96.5 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.4 | 99.6 |
How often the home health team checked patients for depression | 95.2 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 81.1 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 81.4 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
A team of researchers from the Universitat Autònoma de Barcelona (UAB) has discovered that transposons, small DNA sequences that travel through the genomes, can silence the genes adjacent to them by inducing a molecule called antisense RNA.
It's a scenario played out all too frequently: Adult children, worried about the safety of their aging parents, foist devices on them to monitor their safety. And their parents, resentful of having their privacy invaded and losing their independence, resist fiercely.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, is pleased to be named among the Top 50 Best Small and Medium Employers in Canada. Bioniche was ranked number 14 by its employees. Two years ago, the Company attained a 13th place ranking.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-FXIRx, an antisense drug designed to treat clotting disorders. ISIS-FXIRx inhibits the production of Factor XI, a clotting factor that is an important component of the coagulation pathway. Because of its role in the intrinsic coagulation pathway, inhibition of Factor XI could offer an effective approach for preventing the formation of blood clots with a lower risk of bleeding.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 58.9 | 79.6 |
How often patients got better at getting in and out of bed | 76.1 | 81.1 |
How often patients got better at bathing | 70.1 | 82.3 |
How often patients’ breathing improved | 71.3 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 72.9 | 75 |
How often home health patients had to be admitted to the hospital | 12.8 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 13.9 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 36.4 | 94 |
News Archive
A team of researchers from the Universitat Autònoma de Barcelona (UAB) has discovered that transposons, small DNA sequences that travel through the genomes, can silence the genes adjacent to them by inducing a molecule called antisense RNA.
It's a scenario played out all too frequently: Adult children, worried about the safety of their aging parents, foist devices on them to monitor their safety. And their parents, resentful of having their privacy invaded and losing their independence, resist fiercely.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, is pleased to be named among the Top 50 Best Small and Medium Employers in Canada. Bioniche was ranked number 14 by its employees. Two years ago, the Company attained a 13th place ranking.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-FXIRx, an antisense drug designed to treat clotting disorders. ISIS-FXIRx inhibits the production of Factor XI, a clotting factor that is an important component of the coagulation pathway. Because of its role in the intrinsic coagulation pathway, inhibition of Factor XI could offer an effective approach for preventing the formation of blood clots with a lower risk of bleeding.
› Verified 7 days ago
News Archive
A team of researchers from the Universitat Autònoma de Barcelona (UAB) has discovered that transposons, small DNA sequences that travel through the genomes, can silence the genes adjacent to them by inducing a molecule called antisense RNA.
It's a scenario played out all too frequently: Adult children, worried about the safety of their aging parents, foist devices on them to monitor their safety. And their parents, resentful of having their privacy invaded and losing their independence, resist fiercely.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, is pleased to be named among the Top 50 Best Small and Medium Employers in Canada. Bioniche was ranked number 14 by its employees. Two years ago, the Company attained a 13th place ranking.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-FXIRx, an antisense drug designed to treat clotting disorders. ISIS-FXIRx inhibits the production of Factor XI, a clotting factor that is an important component of the coagulation pathway. Because of its role in the intrinsic coagulation pathway, inhibition of Factor XI could offer an effective approach for preventing the formation of blood clots with a lower risk of bleeding.
› Verified 7 days ago
Northwest Community Hospital H Location: 3060 Salt Creek Lane, Arlington Heights, Illinois 60005 Ratings: Phone: (847) 618-7800 | |
4ever Care Home Health Services Inc Location: 2015 South Arlington Heights Road Suite 102, Arlington Heights, Illinois 60005 Ratings: Phone: (847) 357-8008 | |
Symmetrix Home Healthcare, Inc Location: 2015 S Arlington Heights Rd Suite 101, Arlington Heights, Illinois 60005 Ratings: Phone: (847) 430-6771 | |
Bg Home Health Providers, Llc Location: 133 W Rand Road, Arlington Heights, Illinois 60004 Ratings: Phone: (847) 656-5035 | |
Home Health Connect, Inc Location: 2035 S Arlington Heights Road Suite 103, Arlington Heights, Illinois 60005 Ratings: Phone: (847) 258-4603 | |
Citywide Home Health Services, Inc Location: 855 E Golf Road Suite 1128, Arlington Heights, Illinois 60005 Ratings: Phone: (847) 718-1800 |